These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31669777)

  • 21. Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts.
    Coradeghini R; Gioria S; García CP; Nativo P; Franchini F; Gilliland D; Ponti J; Rossi F
    Toxicol Lett; 2013 Mar; 217(3):205-16. PubMed ID: 23246733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Accumulation, Biological Effects and Toxicity of BSA-Coated Gold Nanoparticles in the Mouse Liver, Spleen, and Kidneys.
    Jakic K; Selc M; Razga F; Nemethova V; Mazancova P; Havel F; Sramek M; Zarska M; Proska J; Masanova V; Uhnakova I; Makovicky P; Novotova M; Vykoukal V; Babelova A
    Int J Nanomedicine; 2024; 19():4103-4120. PubMed ID: 38736658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles.
    Xia Q; Huang J; Feng Q; Chen X; Liu X; Li X; Zhang T; Xiao S; Li H; Zhong Z; Xiao K
    Int J Nanomedicine; 2019; 14():6957-6970. PubMed ID: 32021157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo study of spherical gold nanoparticles: inflammatory effects and distribution in mice.
    Chen H; Dorrigan A; Saad S; Hare DJ; Cortie MB; Valenzuela SM
    PLoS One; 2013; 8(2):e58208. PubMed ID: 23469154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles.
    Liu X; Huang N; Wang H; Li H; Jin Q; Ji J
    Biomaterials; 2013 Nov; 34(33):8370-81. PubMed ID: 23932246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles.
    Zhang XD; Wu D; Shen X; Liu PX; Yang N; Zhao B; Zhang H; Sun YM; Zhang LA; Fan FY
    Int J Nanomedicine; 2011; 6():2071-81. PubMed ID: 21976982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue distribution of gold and silver after subacute intravenous injection of co-administered gold and silver nanoparticles of similar sizes.
    Lee JH; Sung JH; Ryu HR; Song KS; Song NW; Park HM; Shin BS; Ahn K; Gulumian M; Faustman EM; Yu IJ
    Arch Toxicol; 2018 Apr; 92(4):1393-1405. PubMed ID: 29450565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles.
    Cho WS; Kim S; Han BS; Son WC; Jeong J
    Toxicol Lett; 2009 Dec; 191(1):96-102. PubMed ID: 19695318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling of clearance, retention, and translocation of inhaled gold nanoparticles in rats.
    Krikas A; Neofytou P; Gakis GP; Xiarchos I; Charitidis C; Tran L
    Inhal Toxicol; 2022; 34(13-14):361-379. PubMed ID: 36053230
    [No Abstract]   [Full Text] [Related]  

  • 30. Differences in uptake of 14 nm PEG-liganded gold nanoparticles into BEAS-2B cells is dependent on their functional groups.
    Vetten M; Gulumian M
    Toxicol Appl Pharmacol; 2019 Jan; 363():131-141. PubMed ID: 30529166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the surface coating on the cytotoxicity, genotoxicity and uptake of gold nanoparticles in human HepG2 cells.
    Fraga S; Faria H; Soares ME; Duarte JA; Soares L; Pereira E; Costa-Pereira C; Teixeira JP; de Lourdes Bastos M; Carmo H
    J Appl Toxicol; 2013 Oct; 33(10):1111-9. PubMed ID: 23529830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of PEGylated Gold Nanoparticles: In Vitro-In Vivo Correlation.
    Dubaj T; Kozics K; Sramkova M; Manova A; Bastús NG; Moriones OH; Kohl Y; Dusinska M; Runden-Pran E; Puntes V; Nelson A; Gabelova A; Simon P
    Nanomaterials (Basel); 2022 Feb; 12(3):. PubMed ID: 35159859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced retention and cellular uptake of nanoparticles in tumors by controlling their aggregation behavior.
    Liu X; Chen Y; Li H; Huang N; Jin Q; Ren K; Ji J
    ACS Nano; 2013 Jul; 7(7):6244-57. PubMed ID: 23799860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiologically based pharmacokinetic modeling of (18)F-SiFAlin-Asp3-PEG1-TATE in AR42J tumor bearing mice.
    Maaß C; Rivas JR; Attarwala AA; Hardiansyah D; Niedermoser S; Litau S; Wängler C; Wängler B; Glatting G
    Nucl Med Biol; 2016 Apr; 43(4):243-6. PubMed ID: 27067044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments.
    Bachler G; Losert S; Umehara Y; von Goetz N; Rodriguez-Lorenzo L; Petri-Fink A; Rothen-Rutishauser B; Hungerbuehler K
    Part Fibre Toxicol; 2015 Jun; 12():18. PubMed ID: 26116549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The biodistribution and immuno-responses of differently shaped non-modified gold particles in zebrafish embryos.
    van Pomeren M; Peijnenburg WJGM; Vlieg RC; van Noort SJT; Vijver MG
    Nanotoxicology; 2019 May; 13(4):558-571. PubMed ID: 30714844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A physiologically based pharmacokinetic model to predict pegylated liposomal doxorubicin disposition in rats and human.
    Montanha MC; Howarth A; Mohamed DA; Loier E; Main L; Rösslein M; Delmaar C; Prina-Mello A; Siccardi M
    Drug Deliv Transl Res; 2022 Sep; 12(9):2178-2186. PubMed ID: 35551629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.
    Sonavane G; Tomoda K; Makino K
    Colloids Surf B Biointerfaces; 2008 Oct; 66(2):274-80. PubMed ID: 18722754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxicity, intracellular localization and exocytosis of citrate capped and PEG functionalized gold nanoparticles in human hepatocyte and kidney cells.
    Tlotleng N; Vetten MA; Keter FK; Skepu A; Tshikhudo R; Gulumian M
    Cell Biol Toxicol; 2016 Aug; 32(4):305-21. PubMed ID: 27184667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticle biodistribution coefficients: A quantitative approach for understanding the tissue distribution of nanoparticles.
    Kumar M; Kulkarni P; Liu S; Chemuturi N; Shah DK
    Adv Drug Deliv Rev; 2023 Mar; 194():114708. PubMed ID: 36682420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.